COMMUNIQUÉS West-GlobeNewswire

Actuate Therapeutics to Participate in Citizens Life Sciences Conference 2025

30/04/2025 - 14:00

CHICAGO and FORT WORTH, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for [...]

Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news

30/04/2025 - 14:00

Phase 2b/3 Alzheimer’s trial enrolment expected to reach 100 this quarter, triggering an interim analysis 6 months later SYDNEY, April 30, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that its [...]

Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate

30/04/2025 - 14:00

- Topline data expected in mid-2025 - SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its [...]

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

30/04/2025 - 14:00

ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for the first quarter ended [...]

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

30/04/2025 - 14:00

Ceribell is one of only 51 companies in the U.S. to achieve FedRAMP High authorization Ceribell's breakthrough technology can now be deployed in federal healthcare facilities, including U.S. Department of Veterans [...]

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

30/04/2025 - 14:00

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today [...]

Intercept Announces Data to be Presented at Digestive Disease Week 2025

30/04/2025 - 14:00

Abstracts include a presidential plenary-selected Phase 2 study evaluating the combination of obeticholic acid and bezafibrate in PBC, along with 10 other abstracts MORRISTOWN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- [...]

Commure’s AI-Powered Ambient Suite Achieves Epic Toolbox Designation for Ambient Voice Recognition

30/04/2025 - 14:00

Commure Ambient AI is now available in Toolbox on Epic Showroom, empowering healthcare organizations to streamline workflows, enhance care delivery, and overcome workforce challenges MOUNTAIN VIEW, Calif., April 30, [...]

Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results

30/04/2025 - 14:00

Hamilton, Bermuda, April 30, 2025 (GLOBE NEWSWIRE) -- Management to host conference call today, April 30, at 8:00 a.m. EDT RNA delivery business progressing with platform development, new applications and collaborations [...]

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

30/04/2025 - 14:00

KIRKLAND, Wash., April 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming [...]

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

30/04/2025 - 14:00

DUBLIN, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a [...]

Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York

30/04/2025 - 14:00

WEST CHESTER, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring [...]

Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor

30/04/2025 - 14:00

More than half say genetic testing for mental health medications could reduce concerns SALT LAKE CITY, April 30, 2025 (GLOBE NEWSWIRE) -- Nearly nine out of ten (89%) Americans diagnosed with depression and/or anxiety [...]

Solid Biosciences to Participate at The Citizens Life Sciences Conference

30/04/2025 - 14:00

CHARLESTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]

BioAtla to Participate in the Citizens Life Sciences Conference

30/04/2025 - 14:00

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the [...]

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

30/04/2025 - 14:03

CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and [...]

Cellectar Announces Plan to Explore Strategic Alternatives

30/04/2025 - 14:05

FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for [...]

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

30/04/2025 - 14:05

DENVER, April 30, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

30/04/2025 - 14:11

— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo,” or the “Company”), a developmental stage [...]